Garg Vipin K 4
4 · Altimmune, Inc. · Filed Jan 27, 2026
Research Summary
AI-generated summary of this filing
Altimmune Director Vipin Garg Receives RSUs, Surrenders Shares
What Happened
Vipin K. Garg, a director of Altimmune, had 42,050 restricted stock units (RSUs) convert into common shares on January 25, 2026. The conversion is reported as an exercise/conversion of a derivative (code M) at $0.00 per share. To cover tax withholding, 17,984 of the newly issued shares were surrendered to the issuer at $5.50 per share, generating $98,912 (code F). Net new shares retained by Garg from this vesting event: 24,066.
Key Details
- Transaction date: January 25, 2026; Form filed January 27, 2026 (appears timely).
- Conversion: 42,050 shares acquired via RSU conversion (M) at $0.00 per share.
- Tax withholding: 17,984 shares surrendered to issuer (F) at $5.50/share for $98,912.
- Net shares received: 42,050 − 17,984 = 24,066 shares added to holdings.
- Shares beneficially owned after the transaction: not specified in the provided filing excerpt.
- Footnotes: F1 = each RSU converts to one common share when vested; F2 = surrendered shares solely to cover taxes; F3 = RSUs vest in substantially equal annual installments over four years from Jan 25, 2024.
Context
This was a vesting/conversion of RSUs rather than a cash purchase or open-market sale. The share surrender is a common, administrative tax-withholding method (not a market sale) and does not necessarily indicate a change in the director’s market view. The filing reflects conversion of a derivative award into shares and the customary withholding to satisfy tax obligations.
Insider Transaction Report
- Exercise/Conversion
Common Stock, par value $0.0001
[F1]2026-01-25+42,050→ 397,132 total - Tax Payment
Common Stock, par value $0.0001
[F2]2026-01-25$5.50/sh−17,984$98,912→ 379,148 total - Exercise/Conversion
Restricted Stock Units
[F1][F3]2026-01-25−42,050→ 84,100 total→ Common Stock, par value $0.0001 (42,050 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.